Ginkgo Bioworks Spins Off Biosecurity Unit, Doubles Autonomous Lab Racks to 100
Ginkgo Bioworks is spinning off its biosecurity business and has cut revenue-generating programs, providing no 2026 revenue guidance while prioritizing cash burn. The company plans to expand its Boston autonomous lab capacity from about 50 to 100 racks, aiming for repeatable multi-year service deals and new cloud lab offerings.
1. Spin-Off and Restructuring
Ginkgo Bioworks has announced the spin-off of its biosecurity business and reduced the number of active revenue-generating programs, foregoing 2026 revenue guidance to focus on managing cash burn.
2. Autonomous Lab Expansion
The company will expand its Boston facility's autonomous lab capacity from approximately 50 to 100 racks, aiming to centralize lab work and support larger-scale automated research operations.
3. Service Model and Commercialization
Ginkgo plans to drive recurring revenue through multi-year solution service deals and expanding its data point and new cloud lab offerings, targeting bioAI model training and smaller batch research services.